Methylprednisolone Dosing in Acute Rheumatoid Arthritis

Chronic Management

Low-dose glucocorticoids (≤10 mg/day prednisone equivalent) effectively suppress inflammation and retard radiographic progression, according to the European League Against Rheumatism, with a strength of evidence rated as high 1
Doses >15 mg/day increase infection risk and should be avoided, as recommended by the American College of Rheumatology, with a strength of evidence rated as moderate 1
Strongly avoid doses >30 mg/day due to incontrovertible evidence of harm without additional benefit, as stated by the European League Against Rheumatism, with a strength of evidence rated as high 2, 3, 4

IM methylprednisolone 120 mg every 3 weeks can be considered as an alternative to oral glucocorticoids in select cases, though evidence is limited to polymyalgia rheumatica, not RA specifically, with a strength of evidence rated as low 3, 4, 5
This regimen may be appropriate when lower cumulative glucocorticoid exposure is desirable (e.g., patients with diabetes, osteoporosis, hypertension, or glaucoma), as suggested by the American College of Rheumatology, with a strength of evidence rated as moderate 3, 4

Reduce prednisone by 1 mg every 4 weeks (or use alternate-day schemes like 10/7.5 mg), as recommended by the European League Against Rheumatism, with a strength of evidence rated as moderate 3, 5, 6
Never taper faster than 1 mg per month to minimize relapse risk, as advised by the American College of Rheumatology, with a strength of evidence rated as high 6

All patients on chronic glucocorticoids require calcium supplementation 800-1,000 mg daily, according to the National Osteoporosis Foundation, with a strength of evidence rated as high 1
All patients on chronic glucocorticoids require vitamin D supplementation 400-800 units daily, as recommended by the Endocrine Society, with a strength of evidence rated as moderate 1
Screening for comorbidities (diabetes, cardiovascular disease, osteoporosis, glaucoma) before initiating therapy is necessary, as stated by the American College of Rheumatology, with a strength of evidence rated as high 2

Do not exceed 10 mg/day prednisone equivalent for chronic therapy—higher doses increase harm without additional benefit, as warned by the European League Against Rheumatism, with a strength of evidence rated as high 1, 2
Do not use high-dose chronic methylprednisolone—this is not supported by evidence and increases adverse events, as stated by the American College of Rheumatology, with a strength of evidence rated as high 2, 3